Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of cardiovascular disease in patients with diabetes: the 2008 Canadian Diabetes Association guidelines.

× No keyword cloud information.

43 in total

Review 1. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines.

Authors: S H Woolf; R Grol; A Hutchinson; M Eccles; J Grimshaw
Journal: BMJ Date: 1999-02-20

2. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk.

Authors: Rod Jackson; Carlene M M Lawes; Derrick A Bennett; Richard J Milne; Anthony Rodgers
Journal: Lancet Date: 2005 Jan 29-Feb 4 Impact factor: 79.321

3. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors:
Journal: BMJ Date: 1998-09-12

4. Effects of a 12-month physical activity counselling intervention on glycaemic control and on the status of cardiovascular risk factors in people with Type 2 diabetes.

Authors: A Kirk; N Mutrie; P MacIntyre; M Fisher
Journal: Diabetologia Date: 2004-05-11 Impact factor: 10.122

5. Translating lifestyle intervention to practice in obese patients with type 2 diabetes: Improving Control with Activity and Nutrition (ICAN) study.

Authors: Anne M Wolf; Mark R Conaway; Jayne Q Crowther; Kristen Y Hazen; Jerry L Nadler; Beverly Oneida; Viktor E Bovbjerg
Journal: Diabetes Care Date: 2004-07 Impact factor: 19.112

6. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors:
Journal: Lancet Date: 1998-09-12 Impact factor: 79.321

Review 7. Lifestyle interventions for type 2 diabetes. Relevance for clinical practice.

Authors: Stewart B Harris; Robert J Petrella; Wendy Leadbetter
Journal: Can Fam Physician Date: 2003-12 Impact factor: 3.275

8. A strategy to reduce cardiovascular disease by more than 80%.

Authors: N J Wald; M R Law
Journal: BMJ Date: 2003-06-28

9. Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators.

Authors:
Journal: JAMA Date: 1992-09-09 Impact factor: 56.272

10. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors: L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal: Lancet Date: 1998-06-13 Impact factor: 79.321

12 in total

1. Choosing the right angiotensin-receptor blocker for patients with diabetes: still controversial.

Authors: Mark E Cooper
Journal: CMAJ Date: 2013-07-08 Impact factor: 8.262

2. Recommending aspirin for primary prevention in diabetic patients: what may we conclude from the data?

Authors: Antonio Nicolucci
Journal: Ther Adv Chronic Dis Date: 2011-05 Impact factor: 5.091

Review 3. Age-Related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk.

Authors: Chee W Chia; Josephine M Egan; Luigi Ferrucci
Journal: Circ Res Date: 2018-09-14 Impact factor: 17.367

4. Antiplatelet therapy for every diabetic person?

Authors: Antonio Nicolucci; Eberhard Standl
Journal: Diabetes Care Date: 2011-05 Impact factor: 19.112

5. Comparative effectiveness of guidelines for the management of hyperlipidemia and hypertension for type 2 diabetes patients.

Authors: Nilay D Shah; Jennifer Mason; Murat Kurt; Brian T Denton; Andrew J Schaefer; Victor M Montori; Steven A Smith
Journal: PLoS One Date: 2011-01-25 Impact factor: 3.240

Review 6. Effects of exercise on cardiovascular risk factors in type 2 diabetes: a meta-analysis.

Authors: Anna Chudyk; Robert J Petrella
Journal: Diabetes Care Date: 2011-05 Impact factor: 19.112

7. A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease.

Authors: Omar S Ahmad; John A Morris; Muhammad Mujammami; Vincenzo Forgetta; Aaron Leong; Rui Li; Maxime Turgeon; Celia M T Greenwood; George Thanassoulis; James B Meigs; Robert Sladek; J Brent Richards
Journal: Nat Commun Date: 2015-05-28 Impact factor: 14.919

Review 8. Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.

Authors: Giorgia De Berardis; Michele Sacco; Giovanni F M Strippoli; Fabio Pellegrini; Giusi Graziano; Gianni Tognoni; Antonio Nicolucci
Journal: BMJ Date: 2009-11-06

9. Physical inactivity and cardiac events: An analysis of the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study.

Authors: Margaret M McCarthy; Frans J Th Wackers; Janice Davey; Deborah A Chyun
Journal: J Clin Transl Endocrinol Date: 2017-06-15

10. Establishment of Clinical Prediction Model Based on the Study of Risk Factors of Stroke in Patients With Type 2 Diabetes Mellitus.

Authors: Rong Shi; Taotao Zhang; Hui Sun; Fan Hu
Journal: Front Endocrinol (Lausanne) Date: 2020-08-25 Impact factor: 5.555